Comparison of 0.25% levobupivacaine 10 ml or 0.125% levobupivacaine 10 ml for Interscalene Brachial Plexus Block for analgesic effect and motor function

Comparison of 0.25% levobupivacaine 10 ml or 0.125% levobupivacaine 10 ml for Interscalene Brachial Plexus Block for analgesic effect and motor function - Comparison of 0.25% levobupivacaine 10 ml or 0.125% levobupivacaine 10 ml for Interscalene Brachial Plexus Block for analgesic effect and motor function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041214

Enrollment

Registered

2020-07-27

Start date

2020-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

In surgery of the shoulder or upper arm, brachial plexus block is performed by the interscalene method after induction of anesthesia. At that time, 10 ml of 0.25% levobupivacaine is used as the drug.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for surgery on shoulder or upper arm

Exclusion criteria

Exclusion criteria: Patients who are taking antipsychotics, patients with mental illness, severe obesity (BMI 35 or higher), patients with chronic pain, patients who are taking opioids and analgesics, patients with dementia, and those who refuse to participate.

Design outcomes

Primary

Measure	Time frame
Motor function and pain within 1 hour after surgery and analgesic duration	—

Countries

Japan

Contacts

Public ContactHayato Terashima

National Defense Medical College Department of Anesthesiology

doc33043@ndmc.ac.jp04-2995-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026